Antigenic drift in H5N1 avian influenza virus in poultry is driven by mutations in major antigenic sites of the hemagglutinin molecule analogous to those for human influenza virus

Journal of Virology

Volumn 85, Issue 17, 2011, Pages 8718-8724

  Cattoli, Giovanni ^a   Milani, Adelaide ^a   Temperton, Nigel ^b   Zecchin, Bianca ^a   Buratin, Alessandra ^a   Molesti, Eleonora ^b   Aly, Mona Meherez ^c   Arafa, Abdel ^c   Capua, Ilaria ^a  

^a ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE   (Italy)

^b MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

^c Agriculture Research Center   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGENIC DRIFT; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; GENETIC REASSORTMENT; HEMAGGLUTINATION INHIBITION TEST; INFLUENZA VIRUS A H5N1; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POULTRY; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; VIRUS CHARACTERIZATION; VIRUS MUTATION; VIRUS NEUTRALIZATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; EGYPT; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NEUTRALIZATION TESTS; POULTRY; REASSORTANT VIRUSES; SEQUENCE ALIGNMENT;

AVES; AVIAN INFLUENZA VIRUS; HUMAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE;

EID: 80052302754     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02403-10     Document Type: Article

References (43)

1. Arafa, A., D. L. Suarez, M. K. Hassan, and M. M. Aly. 2010. Phylogenetic analysis of hemagglutinin and neuraminidase genes of highly pathogenic avian influenza H5N1 Egyptian strains isolated from 2006 to 2008 indicates heterogeneity with multiple distinct sublineages. Avian Dis. 54:345-349.
2. Balish, A. L., et al. 2010. Antigenic and genetic diversity of highly pathogenic avian influenza A (H5N1) viruses isolated in Egypt. Avian Dis. 54:329-334.
3. Cattoli, G., et al. 2009. Highly pathogenic avian influenza virus subtype H5N1 in Africa: a comprehensive phylogenetic analysis and molecular characterization of isolates. PLoS One 4:e4842.
4. Duan, L., et al. 2008. The development and genetic diversity of H5N1 influenza virus in China, 1996-2006. Virology 380:243-254.
5. Duvvuri, V. R., B. Duvvuri, W. R. Cuff, G. E. Wu, and J. Wu. 2009. Role of positive selection pressure on the evolution of H5N1 hemagglutinin. Genomics Proteomics Bioinformatics 7:47-56.
6. Gamblin, S. J., et al. 2004. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303:1838-1842.
7. Grund, C., et al. 2011. Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate. Vaccine [Epub ahead of print.] doi:10.1016/j.vaccine.2011.01.006.
8. Guex, N., and M. C. Peitsch. 1997. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18:2714-2723.
9. Ha, Y., D. J. Stevens, J. J. Skehel, and D. C. Wiley. 2002. H5 avian and H9 swine influenza virus haemagglutinin structures: possible origin of influenza subtypes. EMBO J. 21:865-875.
10. Hafez, M. H., et al. 2010. Avian influenza H5N1 virus infections in vaccinated commercial and backyard poultry in Egypt. Poult. Sci. 89:1609-1613.
11. Hensley, S. E., et al. 2009. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326:734-736.
12. Hoffmann, E., A. S. Lipatov, R. J. Webby, E. A. Govorkova, and R. G. Webster. 2005. Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines Proc. Natl. Acad. Sci. U. S. A. 102:12915-12920.
13. Hoffmann, E., S. Krauss, D. Perez, R. Webby, and R. G. Webster. 2002. Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20:3165-3170.
14. Jadhao, S. J., C. W. Lee, M. Sylte, and D. L. Suarez. 2009. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens. Vaccine 27:6247-6260.
15. Jin, H., et al. 2005. Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. Virology 336:113-119.
16. Kaverin, N. V., et al. 2007. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J. Virol. 81:12911-12917.
17. Kaverin, N. V., et al. 2004. Differences and similarities in the structure of the antigenic epitopes on influenza A virus hemagglutinin molecule of different subtypes. Proc. Int. Conf. Options Control Influenza V. Int. Congr. Ser. 1263:682-686.
18. Kaverin, N. V., et al. 2002. Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants. J. Gen. Virol. 83:2497-2505.
19. Kim, J. K., et al. 2010. Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry. Proc. Natl. Acad. Sci. U. S. A. 107:11044-11049.
20. Koel, B. F., et al. 2010. Antigenic evolution of influenza A (H3N2) virus is dictated by 7 residues in the hemagglutinin protein, abstr. O-905, p. 84. Abstr. Options Control Influenza VII. Hong Kong SAR, China.
21. Kolaskar, A. S., and P. C. Tongaonkar. 1990. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 276:172-174.
22. Lee, C. W., D. A. Senne, and D. L. Suarez. 2004. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J. Virol. 78:8372-8381.
23. Li, J., et al. 2009. Fine antigenic variation within H5N1 influenza virus hemagglutinin's antigenic sites defined by yeast cell surface display. Eur. J. Immunol. 39:3498-3510.
24. Liu, J., et al. 2009. Structures of receptor complexes formed by hemagglutinins from the Asian influenza pandemic of 1957. Proc. Natl. Acad. Sci. U. S. A. 106:17175-17180.
25. Ndifon, W., N. S. Wingreen, and S. A. Levin. 2009. Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines. Proc. Natl. Acad. Sci. U. S. A. 106:8701-8706.
26. Nobusawa, E., T. Aoyama, H. Kato, Y. Suzuki, Y. Tateno, and K. Nakajima. 1991. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 182:475-485.
27. OIE World Organization for Animal Health. 2008. Manual of diagnostic tests and vaccines for terrestrial animals. OIE-World Organization for Animal Health, Paris, France.
28. Peyre, M., et al. 2009. Avian influenza vaccination in Egypt: limitations of the current strategy. J. Mol. Genet. Med. 3:198-204.
29. ProMed. 2009. Avian influenza (50): Egypt, China, Indonesia, FAO update; archive no. 20090902.3089. ProMed, Geneva, Switzerland.
30. Rauw, F., et al. 2011. Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains. Vaccine 29:2590-2600.
31. Rowe, T., et al. 1999. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 37:937-943.
32. Shih, A. C., T. C. Hsiao, M. S. Ho, and W. H. Li. 2007. Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc. Natl. Acad. Sci. U. S. A. 104:6283-6288.
33. Stevens, J., et al. 2006. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312:404-410.
34. Swayne, D. E., and D. Kapczynski. 2008. Strategies and challenges for eliciting immunity against avian influenza virus in birds. Immunol. Rev. 225:314-331.
35. Terregino, C., et al. 2010. Evaluation of the protection induced by avian influenza vaccines containing a 1994 Mexican H5N2 LPAI seed strain against a 2008 Egyptian H5N1 HPAI virus belonging to clade 2.2.1 by means of serological and in vivo tests. Avian Pathol. 39:215-222.
36. Wang, C. C., et al. 2009. Glycans on influenza hemagglutinin affect receptor binding and immune response. Proc. Natl. Acad. Sci. U. S. A. 106:18137-18142.
37. WHO/OIE/FAO H5N1 Evolution Working Group. 2008. Toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1). Emerg. Infect. Dis. 14:e1.
38. Wilson, I. A., J. J. Skehel, and D. C. Wiley. 1981. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289:366-373.
39. World Health Organization. 2011. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/disease/avian_influenza/guidelines/h5n1virus/en/index.html.
40. Wu, W. L., et al. 2008. Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007. J. Virol. 82:1798-1807.
41. Yamada, S., et al. 2006. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 444:378-382.
42. Yang, Z. Y., et al. 2007. Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity. Science 317:825-828.
43. Yen, H. L., et al. 2009. Changes in H5N1 influenza virus hemagglutinin receptor binding domain affect systemic spread. Proc. Natl. Acad. Sci. U. S. A. 106:286-291.